When was the ZZZ 1.6 release date? Now that ZZZ 1.5 is over, it’s time to start looking ahead to what awaits us in Version 1.6 “Among the Forgotten Ruins.” If you’re already saving up your ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is engaged in discovering, inventing, developing, manufacturing, and commercializing medicines for treating various diseases. Analyst John Newman ...

Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) presented positive results from the pivotal ADEPT Phase 2/3 trial evaluating the investigational use of Dupixent in adults with moderate-to-severe ...

The agreement was signed in a letter of intent March 3 to set the groundwork for whether government health programs in different provinces and territories will cover the drug's cost for patients, ...

Genshin Impact 5.4 banners released on February 12, 2025 and will end on March 25, 2025. First half of 5.4 version will feature Yumemizuki Mizuki and Sigewinne, while the second half will feature ...

It has been about a month since the last earnings report for Regeneron (REGN). Shares have lost about 4.1% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.

The Federal Circuit upheld a preliminary injunction blocking the launch of a Celltrion Inc. biosimilar version to Regeneron Pharmaceuticals Inc. ‘s Eylea blockbuster eye-disease biologic.